Your browser is no longer supported. Please, upgrade your browser.
ABT Abbott Laboratories daily Stock Chart
Abbott Laboratories
IndexS&P 500 P/E60.90 EPS (ttm)0.67 Insider Own0.30% Shs Outstand1.48B Perf Week-0.71%
Market Cap59.89B Forward P/E16.65 EPS next Y2.43 Insider Trans16.58% Shs Float1.46B Perf Month-3.46%
Income993.00M PEG6.41 EPS next Q0.65 Inst Own73.60% Short Float4.93% Perf Quarter-6.11%
Sales20.71B P/S2.89 EPS this Y53.50% Inst Trans-0.09% Short Ratio7.73 Perf Half Y-6.82%
Book/sh14.07 P/B2.88 EPS next Y10.24% ROA- Target Price47.50 Perf Year-4.55%
Cash/sh- P/C- EPS next 5Y9.51% ROE- 52W Range35.34 - 45.50 Perf YTD-7.55%
Dividend1.04 P/FCF- EPS past 5Y-10.30% ROI7.70% 52W High-10.99% Beta1.35
Dividend %2.57% Quick Ratio- Sales past 5Y-10.30% Gross Margin56.90% 52W Low14.61% ATR0.82
Employees74000 Current Ratio- Sales Q/Q3.00% Oper. Margin14.70% RSI (14)41.93 Volatility2.00% 1.94%
OptionableYes Debt/Eq- EPS Q/Q-161.10% Profit Margin6.60% Rel Volume0.78 Prev Close40.74
ShortableYes LT Debt/Eq- EarningsOct 19 BMO Payout112.60% Avg Volume9.32M Price40.50
Recom1.90 SMA20-2.64% SMA50-3.89% SMA2000.45% Volume7,273,500 Change-0.59%
Jul-21-16Reiterated Barclays Overweight $48 → $50
Jun-21-16Upgrade Edward Jones Hold → Buy
Apr-11-16Reiterated RBC Capital Mkts Outperform $45 → $48
Jan-04-16Downgrade Morgan Stanley Overweight → Equal-Weight
Dec-07-15Upgrade Jefferies Hold → Buy
Nov-13-15Downgrade Goldman Buy → Neutral
Oct-09-15Reiterated RBC Capital Mkts Outperform $55 → $51
Oct-07-15Upgrade Barclays Equal Weight → Overweight $55 → $52
Jul-23-15Reiterated Stifel Buy $53 → $58
Jul-23-15Reiterated RBC Capital Mkts Outperform $51 → $55
Jul-23-15Reiterated Barclays Equal Weight $53 → $55
Apr-23-15Reiterated Stifel Buy $52 → $53
Mar-27-15Reiterated Barclays Equal Weight $48 → $52
Jan-30-15Reiterated Stifel Buy $47 → $49
Jan-30-15Reiterated Barclays Equal Weight $43 → $48
Sep-22-14Reiterated RBC Capital Mkts Outperform $44 → $48
Jul-17-14Reiterated Stifel Buy $42 → $47
Jul-17-14Reiterated Barclays Equal Weight $40 → $43
Mar-10-14Initiated Singular Research Sell $30
Dec-16-13Reiterated Deutsche Bank Hold $37 → $39
Oct-23-16 03:56PM  Alere's Shareholders Approve Merger With Abbott
Oct-21-16 06:04PM  JNJ Moved to Restructure Its Medical Devices Business in 3Q16
11:44AM  Top Research Reports for Goldman Sachs, Verizon, Abbott & Others
11:09AM  Earnings show signs of life
10:05AM  A Look at Johnson & Johnsons Segment-Wise Performance in 3Q16
Oct-20-16 05:48PM  Another Health Care Chart Looks Sick
05:28PM  Abbott, St. Jude Medical: Agreement Reached in Sale of Vascular Closure Products toTerumo
01:41PM  Amid Headline Risk, Barclays Says St. Jude's Pipeline Underestimated
11:17AM  People's Republic of China Clears Abbott Acquisition of Alere PR Newswire
09:17AM  Abbott, St. Jude Divests $1B in Assets (ABT, STJ) at Investopedia
Oct-19-16 10:14PM  [$$] Abbott Labs Swings to Loss After Booking Charge on Mylan Stake at The Wall Street Journal
05:59PM  Abbott Releases 3rd Quarter Results
04:18PM  Abbott Labs, St. Jude Lurch On Muddy Waters Tussle Despite Q3 Sales Beats
03:14PM  Abbott Labs (ABT) Beats on Q3 Earnings, Narrows 2016 View
01:19PM  Drug Wars: California Vote Could Limit Price Hikes at Investopedia
12:48PM  Abbott moves ahead on St. Jude, Alere deals, but investors fret Reuters
11:55AM  Jim Cramer: Drug Stocks Feeling Political Pressure at TheStreet
11:49AM  [$$] St. Jude Medical's Sales Rise 12% at The Wall Street Journal
11:34AM  Abbott CEO Is Unfazed by Muddy Waters' Attack on St. Jude
10:52AM  Edited Transcript of ABT earnings conference call or presentation 19-Oct-16 1:00pm GMT
10:05AM  St. Jude Spars With Muddy Waters After Earnings Miss
09:54AM  Heres Why Investors Are Watching Sangamo Biosciences, GNC Holdings, and Three Other Stocks Today at Insider Monkey
09:29AM  Abbott's third-quarter earnings edge past Street Reuters
09:29AM  Abbott Labs (ABT) Beats on Earnings & Sales in Q3
09:00AM  Abbott Laboratories Earnings Call scheduled for 9:00 am ET today
08:28AM  Abbott Posts Slight Q3 Beat, Narrows Outlook
08:03AM  Abbott's third-quarter revenue rises nearly 3 percent Reuters
08:02AM  Abbott Labs (ABT) Stock Up on Q3 Earnings Beat
07:54AM  Abbott reports 3Q loss
07:53AM  ABBOTT LABORATORIES Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
07:48AM  Abbott Posts Surprise Net Loss as Value of Mylan Stake Tanks at Bloomberg
07:45AM  Abbott Reports Third-Quarter 2016 Results PR Newswire
07:07AM  Q3 2016 Abbott Laboratories Earnings Release - Before Market Open
Oct-18-16 06:18PM  3 Top Dividend Stocks to Buy Now at Motley Fool
05:41PM  3 Companies with Perfect Earnings Records
03:45PM  St. Jude, Abbott to sell product lines to Japanese company in $1.12B deal at
02:20PM  Abbott, St. Jude Float Antitrust Spinoff by FTC
01:03PM  Your Two Minute Earnings Preview for Abbott Labs (ABT) Stock
12:00PM  Cincinnati firm to pay $28M to settle kickback claims at
11:00AM  Abbott and St. Jude to sell products to Terumo
10:10AM  Pharma Boosts Johnson & Johnson Despite Falling Consumer Sales at Motley Fool
08:47AM  [$$] Abbott, St. Jude Medical to Sell $1.1 Billion in Assets at The Wall Street Journal
08:20AM  St. Jude and Abbott to sell some medical devices for $1.12 bln
08:12AM  Abbott Labs, St. Jude agree to sell assets for $1.1 billion after merger closes at MarketWatch
08:00AM  St. Jude Medical and Abbott to Sell Portion of Vascular Closure and Electrophysiology Businesses to Terumo Corporation PR Newswire
Oct-17-16 08:50PM  [$$] St. Jude Medical Forms Cybersecurity Advisory Group at The Wall Street Journal
02:58PM  Pfizer Refuses to Go the Spinoff Route
02:44PM  What to Look for When Abbott Labs (ABT) Reports Q3 Earnings
02:04PM  What to Expect from Abbott Laboratories 3Q16 Earnings
12:04PM  Analyzing Abbott Laboratories 3Q16 Revenue Estimates
10:25AM  What Are Analysts Recommending for Abbott ahead of 3Q16 Results?
10:25AM  Omnicare to pay $28 mln to settle charges it got kickbacks from Abbott Labs Reuters
09:00AM  Medical Technology Sales To Hit $500B Within Five Years at Forbes
08:05AM  Could Johnson & Johnsons Earnings Grow in 3Q16?
Oct-14-16 06:13PM  Cramer's game plan: What to expect from McDonald's, GE, the Fed & more next week at CNBC
Oct-13-16 08:40PM  INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Abbott Laboratories and Encourages Investors with Losses to Contact the Firm Business Wire
06:40PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abbott Laboratories - ABT PR Newswire
12:05PM  Abbott Develops AML Tests With Celgene and Agios
10:50AM  J&J (JNJ) Likely to Beat Earnings Estimates in Q3 Again
10:10AM  Celgene/Agios Ink Deals with Abbott to Identify IDH Mutations
09:58AM  Abbott Labs (ABT) Q3 Earnings: What's Ahead for the Stock?
09:01AM  Blog Coverage Celgene and Agios Team up with Abbott
Oct-12-16 03:41PM  Can Johnson & Johnson Keep Growing Healthier? at Motley Fool
01:47PM  Abbott Tumbled on St. Jude Medical's News
12:40PM  Celgene, Agios, Abbott Team For Test (CELG, AGIO) at Investopedia
11:37AM  St. Jude Medical Shares Fall Amid Device Failure (STJ, ABT) at Investopedia
10:41AM  Heres Why Stanley Black & Decker, Celgene Corporation, and Three Other Stocks Are Trending Today at Insider Monkey
12:12AM  St. Jude Medical Warns of Battery Problems With Heart Products at The Wall Street Journal
12:05AM  St. Jude Medical Warns of Battery Problems With Heart Products at The Wall Street Journal
Oct-11-16 11:43PM  Asian stocks dip taking cue from Wall Street, doubts on oil AP -5.38%
04:24PM  St. Jude warns of battery defect in some heart devices
12:48PM  5 Stocks, 5 trades: AA, TWLO & more
12:40PM  Jim Cramer: St. Jude Battery Woes Big But Not a Dealbreaker at TheStreet
11:29AM  St. Jude Device Failures Won't Ruin Abbott Deal
11:04AM  Why the Dental Segment Could Be a Growth Area for Danaher in China
10:24AM  Jim Cramer -- Will St. Jude Product Alert Affect Abbott's Offer?
10:06AM  Danaher Leads Healthcare Peers on YTD Returns
09:22AM  Cramer's Mad Dash: St. Jude falls
08:19AM  Abbott Laboratories breached its 50 day moving average in a Bullish Manner : ABT-US : October 11, 2016
07:00AM  St. Jude warns of heart-device battery issue linked to 2 deaths
Oct-07-16 02:28PM  Did Pfizer's No-Split Decision Cost Investors a Lot of Money? at Motley Fool
12:54PM  Did Medtronic Increase Dividend Payments This Quarter?
11:20AM  Abbott Laboratories : ABT-US: Dividend Analysis : July 15th, 2016 (record date) : By the numbers : October 7, 2016
Oct-05-16 08:04AM  Analysts Strong Buy Recommendation for Thermo Fisher Scientific
Oct-04-16 11:04AM  Thermo Fisher Scientifics Latest Valuation
06:01AM  EU ruling on $25 billion Abbott, St. Jude deal due by November 9 Reuters
05:57AM  EU ruling on $25 bln Abbott, St Jude deal due by Nov. 9 Reuters
Oct-03-16 06:23PM  Spiros Segalas Takes 3-for-2 in Third Quarter
05:23PM  Endo International Reports Positive Phase II Data on Xiaflex
03:39PM  J&J's Psoriasis Drug Shows Superior Efficacy Over Humira
11:06AM  Medtronic: The Latest Analyst Recommendations
10:06AM  A Look at Thermo Fisher Scientifics Recent Product Approvals
Oct-01-16 01:30AM  The Smart Money Loves These Dividend Aristocrats: Wal-Mart, Chevron, More at Insider Monkey
Sep-30-16 07:13PM  [$$] Baker & Eastlack Ventures Raising $25M Medical-Device Fund at The Wall Street Journal
06:47PM  Abbott Receives FDA Approval for Freestyle Libre
04:40PM  Medical Device ETF Near Highs As Products, Equipment Groups Outperform
11:05AM  Delving into Zimmer Biomets Acquisition of CD Diagnostics
Sep-29-16 10:03AM  7 Healthcare Stocks in Focus on World Heart Day
Sep-28-16 03:39PM  Better Buy: Johnson & Johnson vs. AbbVie at Motley Fool
12:19PM  Will Abbott (ABT) Stock Be Helped By FDA Approval of Glucose Monitoring System?
Abbott Laboratories manufactures and sells health care products worldwide. The company's Established Pharmaceutical Products segment offers branded generic pharmaceuticals to treat pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptoms; gynecological disorders; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Meniere's disease and vestibular vertigo; pain, fever, and inflammation; migraines; anti-infective clarithromycin; and influenza vaccines, as well as to regulate physiological rhythm of the colon. Its Diagnostic Products segment provides immunoassay and clinical chemistry systems; assays used to screen and/or diagnosis cancer, cardiac, drugs of abuse, fertility, infectious diseases, and therapeutic drug monitoring; hematology systems and reagents; diagnostic systems and cartridges; instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents; genomic-based tests; informatics and automation solutions; and instrument used to identify infection-causing pathogens. The company's Nutritional Products segment provides pediatric and adult nutritional products, such as prepared infant and follow-on formulas. Its Vascular Products segment offers coronary, endovascular, vessel closure, and structural heart devices to treat vascular disease. The company also provides blood and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes; and medical devices for the eye, such as cataract and LASIK surgery, contact lens care, and dry eye products. It serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company has strategic alliance with Fonterra. Abbott Laboratories was founded in 1888 and is headquartered in Abbott Park, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Salvadori Daniel Gesua SiveSenior Vice PresidentSep 26Sale41.7181533,99458,976Sep 28 05:05 PM
FREYMAN THOMAS CExecutive Vice PresidentJul 29Option Exercise25.2556,0001,413,782438,682Jul 29 05:04 PM
Fussell Stephen RExecutive Vice PresidentJul 28Option Exercise25.2541,5001,047,713196,467Jul 29 05:03 PM
Fussell Stephen RExecutive Vice PresidentJul 28Sale45.0041,5001,867,640154,967Jul 29 05:03 PM
Warmuth Michael JExecutive Vice PresidentJul 26Option Exercise25.2526,800676,59581,811Jul 27 04:43 PM
Warmuth Michael JExecutive Vice PresidentJul 26Sale43.4926,8001,165,45755,011Jul 27 04:43 PM
WHITE MILES DChairman and CEOJul 25Option Exercise25.25550,00013,885,3552,010,517Jul 27 04:27 PM
Funck Robert EVice President, ControllerJul 25Option Exercise25.2526,800676,595111,819Jul 27 04:44 PM
WHITE MILES DChairman and CEOJul 25Buy43.3417,933777,1622,742,017Jul 27 04:31 PM
WHITE MILES DChairman and CEOJul 25Buy43.26176,8047,648,8232,724,084Jul 27 04:30 PM
WHITE MILES DChairman and CEOJul 25Buy43.19181,2637,828,6282,434,327Jul 27 04:29 PM
WHITE MILES DChairman and CEOJul 25Buy43.34112,9534,895,2172,547,280Jul 27 04:29 PM
WHITE MILES DChairman and CEOJul 25Buy43.18242,54710,472,9392,253,064Jul 27 04:27 PM
Funck Robert EVice President, ControllerJul 25Sale43.0826,8001,154,54485,019Jul 27 04:44 PM
ALLEN HUBERT LExecutive Vice PresidentJun 28Option Exercise20.753,40070,54591,857Jun 30 05:58 PM
ALLEN HUBERT LExecutive Vice PresidentJun 28Sale37.143,400126,27688,457Jun 30 05:58 PM
Watkin JaredSenior Vice PresidentJun 15Sale37.6355220,77046,562Jun 17 05:05 PM
YOOR BRIAN BSenior Vice President and CFOJun 01Sale39.4956522,31249,617Jun 03 05:10 PM
NATH DEEPAK S.Senior Vice PresidentApr 28Sale41.31532,18947,382Apr 29 05:01 PM
Contreras JaimeSenior Vice PresidentMar 31Sale41.7846219,3042,426Apr 01 05:01 PM
Ford Robert BExecutive Vice PresidentFeb 29Sale39.281,70667,02060,789Mar 02 07:32 PM
NATH DEEPAK S.Senior Vice PresidentFeb 29Sale39.2779331,14247,571Mar 02 07:30 PM
Fussell Stephen RExecutive Vice PresidentFeb 29Sale39.261,40255,044154,967Mar 02 07:28 PM
Contreras JaimeSenior Vice PresidentFeb 29Sale38.9410,617413,40947,667Mar 02 07:28 PM
Blaser Brian JExecutive Vice PresidentFeb 29Sale39.291,54360,626129,482Mar 02 07:12 PM
ALLEN HUBERT LExecutive Vice PresidentFeb 29Sale39.291,54360,61888,457Mar 02 07:11 PM
ASHLEY RICHARD WExecutive Vice PresidentFeb 29Sale39.283,086121,221354,517Mar 02 07:10 PM
Salvadori Daniel Gesua SiveSenior Vice PresidentFeb 29Sale39.2688134,58961,792Mar 02 07:02 PM
YOOR BRIAN BSenior Vice President and CFOFeb 29Sale39.1286533,84351,385Mar 02 07:01 PM
Mason Heather LExecutive Vice PresidentFeb 29Sale39.273,032119,05565,102Mar 02 06:49 PM
Funck Robert EVice President, ControllerFeb 29Sale39.301,33352,39385,019Mar 02 06:07 PM
Warmuth Michael JExecutive Vice PresidentFeb 29Sale38.849,399365,09355,011Mar 02 05:14 PM
Pavee Jean-YvesSenior Vice PresidentFeb 29Sale39.241,66565,32636,149Mar 02 05:09 PM
NATH DEEPAK S.Senior Vice PresidentFeb 22Sale39.0931912,47150,404Feb 23 05:44 PM
Watkin JaredSenior Vice PresidentFeb 22Sale39.0955421,65848,535Feb 23 05:38 PM
NATH DEEPAK S.Senior Vice PresidentFeb 16Sale37.131716,34934,941Feb 17 05:57 PM
WHITE MILES DChairman and CEODec 16Option Exercise21.22438,0009,294,0971,832,153Dec 18 05:01 PM
WHITE MILES DChairman and CEODec 16Sale46.00438,00020,149,9581,394,153Dec 18 05:01 PM